J. Goldman & Co »

First Tracks Biotherapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $943k 47k 20.12

More positions owned by J. Goldman & Co

Siriusxm Holdings Common Stock (SIRI)
Ishares Tr Russell 2000 Etf (IWM)
AutoZone (AZO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Warby Parker Cl A Com (WRBY)
Select Sector Spdr Tr St Str Stapl Etf (XLP)
Grocery Outlet Hldg Corp (GO)
Sentinelone Cl A (S)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Steven Madden (SHOO)
Amer Sports Com Shs (AS)
Academy Sports & Outdoor (ASO)
Destiny Tech100 Com Shs (DXYZ)
Roku Com Cl A (ROKU)

View all positions for J. Goldman & Co

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics